Hit HIV-1 hard, but only when necessary
- 1 June 2000
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 355 (9221) , 2147-2152
- https://doi.org/10.1016/s0140-6736(00)02388-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Benchmarks for antiretroviral therapyJournal of Clinical Investigation, 2000
- Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNAJournal of Clinical Investigation, 2000
- Discontinuation of Anticytomegalovirus Therapy in Patients With HIV Infection and Cytomegalovirus RetinitisJAMA, 1999
- Variations in the Care of HIV-Infected Adults in the United StatesPublished by American Medical Association (AMA) ,1999
- Therapeutic Strategies for HIV Infection — Time to Think HardNew England Journal of Medicine, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Perspectives series: host/pathogen interactions. Dynamics of HIV-1 replication in vivo.Journal of Clinical Investigation, 1997
- A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic MillimeterNew England Journal of Medicine, 1996
- The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990